DOI QR코드

DOI QR Code

Antitumor effects of octyl gallate on hypopharyngeal carcinoma cells

  • NTK, Trang (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Chosun University) ;
  • Yoo, Hoon (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Chosun University)
  • Received : 2020.08.15
  • Accepted : 2020.12.16
  • Published : 2020.12.31

Abstract

The antitumor effects of octyl gallate (OG) were investigated on FaDu human hypopharyngeal squamous carcinoma cells. At various concentrations, OG inhibited the proliferation of FaDu cells by suppressing cell cycle regulators and induced apoptosis by activating caspase 3 and its downstream poly (ADP-ribose) polymerase, thereby damaging DNA. Immunoblotting demonstrated that OG significantly suppressed the expression of integrin family proteins (integrin α4, αv, β3, β4), hindering cell adhesion. The reduced expression of integrins subsequently mediated the mitogen-activated protein kinase signaling pathway to stimulate the activation of extracellular signal-regulated kinases and c-jun N-terminal kinases, leading to apoptosis. Thus, OG demonstrated antitumor activity on hypopharyngeal squamous carcinoma cells by suppressing cell proliferation and inducing apoptosis.

Keywords

References

  1. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-15. doi: 10.1056/NEJMoa070956.
  2. Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 2011;57:19-37. doi: 10.1111/j.1600-0757.2011.00401.x.
  3. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002;52:195-215. doi: 10.3322/canjclin.52.4.195.
  4. Scully C, Porter S. ABC of oral health. Oral cancer. BMJ 2000;321:97-100. doi: 10.1136/bmj.321.7253.97.
  5. Wolf VG, Bonacorsi C, Raddi MSG, da Fonseca LM, Ximenes VF. Octyl gallate, a food additive with potential beneficial properties to treat Helicobacter pylori infection. Food Funct 2017;8:2500-11. doi: 10.1039/c7fo00707h.
  6. Khaledi H, Alhadi AA, Yehye WA, Ali HM, Abdulla MA, Hassandarvish P. Antioxidant, cytotoxic activities, and structure-activity relationship of gallic acid-based indole derivatives. Arch Pharm (Weinheim) 2011;344:703-9. doi: 10.1002/ardp.201000223.
  7. Serrano A, Palacios C, Roy G, Cespon C, Villar ML, Nocito M, Gonzalez-Porque P. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys 1998;350:49-54. doi: 10.1006/abbi.1997.0474.
  8. Sales MS, Roy A, Antony L, Banu SK, Jeyaraman S, Manikkam R. Octyl gallate and gallic acid isolated from Terminalia bellarica regulates normal cell cycle in human breast cancer cell lines. Biomed Pharmacother 2018;103:1577-84. doi: 10.1016/j.biopha.2018.04.182.
  9. de Cordova CA, Locatelli C, Assuncao LS, Mattei B, Mascarello A, Winter E, Nunes RJ, Yunes RA, Creczynski-Pasa TB. Octyl and dodecyl gallates induce oxidative stress and apoptosis in a melanoma cell line. Toxicol In Vitro 2011;25:2025-34. doi: 10.1016/j.tiv.2011.08.003.
  10. Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci 2009;122(Pt 2):159-63. doi: 10.1242/jcs.018093.
  11. Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 2001;114(Pt 14):2553-60. https://doi.org/10.1242/jcs.114.14.2553
  12. Lee J, Hong J, Nam TG, Peters EC, Orth AP, Geierstanger BH, Goldfinger LE, Ginsberg MH, Cho CY, Schultz PG. A small molecule inhibitor of alpha4 integrin-dependent cell migration. Bioorg Med Chem 2009;17:977-80. doi: 10.1016/j.bmc.2008.02.067.
  13. Lu TN, Ganganna B, Pham TT, Vo AV, Lu TP, Nguyen HT, Nguyen MT, Huynh PN, Truong NT, Lee J. Antitumor effect of the integrin α4 signaling inhibitor JK273 in non-small cell lung cancer NCI-H460 cells. Biochem Biophys Res Commun 2017;491:355-60. doi: 10.1016/j.bbrc.2017.07.096.
  14. Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, He C, Pan H. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett 2014;344:174-9. doi: 10.1016/j.canlet.2013.11.019.
  15. Lu Z, Xu S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 2006;58:621-31. doi: 10.1080/15216540600957438.
  16. Vilela B, Pagès M, Lumbreras V. Regulation of MAPK signaling and cell death by MAPK phosphatase MKP2. Plant Signal Behav 2010;5:1497-500. doi: 10.4161/psb.5.11.13645.
  17. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002;277:12710-7. doi: 10.1074/jbc.M111598200.
  18. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001;89:1104-10. doi: 10.1161/hh2401.101084.